Xeroderma pigmentosum (XP) is a condition in which early diagnosis and prompt initiation of a consistent protective strategy are central to long-term outcomes. The first-line protocol defines a rigorous approach to ultraviolet light exposure management.
When managing XP, the clinical priority is minimising cumulative ultraviolet light exposure from the point of diagnosis. Early recognition of cutaneous disease and timely entry into a structured protective regimen are key determinants of prognosis.
Treatment approach: The first-line protocol involves strict measures to limit ultraviolet light exposure, supported by structured sun protection education delivered by professional staff. The complete specification of protective measures, monitoring considerations, and full regimen structure is available in the linked protocol.